One of the main goals of NurseTrust is to identify and guide upcoming nurse leaders who can contribute to the advancement of population health and healthcare.
The researchers found that samples from patients with COVID-19 showed strong reactivity to both the full-length S protein and the RBD.
The incidence of osimertinib-associated grade 3 or higher cardiac adverse events was 4.9% in a retrospective NSCLC population.
A subset of testicular cancer survivors experience persistent, treatment-related, long-term adverse health outcomes that affect their ability to work.
Patients with cancer aged 65 and older are likely to be taking 5 or more medications before treatment with IV chemotherapy, which can complicate posttreatment care.
In a registry study, patients with HBV or HCV who began low-dose aspirin had lower rates of HCC and 10-year liver-related mortality compared with nonusers.
In a small study, single-dose instillation of mitomycin C immediately following therapeutic ureteroscopy for upper tract urothelial carcinoma was associated with an 87% decreased risk of urothelial recurrence.
Herein, spiritual care was defined as “that which recognizes and responds to the needs of the human spirit, including the need for meaning, purpose, and connection.”
Given the difficulty in definitevely diagnosing acute promyelocytic leukemia, researchers sought to develop a rapid point of care diagnostic assay.
Identification of the underlying pattern for ruxolitinib failure in patients with myelofibrosis is a significant factor in determining appropriate treatment.
A phase 3 trial of elderly patients with nonsquamous NSCLC demonstrated that carboplatin + pemetrexed prolonged survival with an improved safety profile compared with docetaxel.
With adequate support from a multidisciplinary care team, outpatient induction chemotherapy was safe for these patients.
A large retrospective analysis demonstrated that a delay of 4 to 8 weeks for adjuvant radiotherapy following surgical resection of glioblastoma improved survival.
Although most notably associated with erythrocytosis, hematologic manifestations of polycythemia vera may also include leukocytosis and thrombocytosis.
Rituximab has some single-agent activity in HCL, but there is evidence that it may eliminate MRD when used with cladribine or pentostatin.
The approval was based on data from the CASPIAN study, an active-controlled, open-label trial that investigated the combination of durvalumab plus chemotherapy vs chemotherapy alone.
In an effort to gather data on hazardous drug exposure, researchers surveyed oncology nurses regarding spills and use of personal protective equipment at 12 participating academic infusion centers.
The COVID-19 pandemic is challenging nurses and hospitals to find unique solutions to maintain patient care in an unprecedented situation.
The researchers found that high rates of remission could be achieved with induction therapy using rituximab/bendamustine in addition to rituximab/cytarabine.
A retrospective analysis found encouraging evidence for the use of BvB in treatment of RR-cHL.